Amy Brooks, PhD, CGC

In 2023 Dr. Brooks was appointed to the Virginia Newborn Bloodspot Screening Program Advisory Committee. 

• Brooks, A. N., Byers, H. A., Vangala, J.R., Grible, J. M., Feygin, A., Clevenger, C. V., Harrell, J. C., & Radhakrishnan, S. K. (2023). Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer. Scientific Reports, 13(1):15843.
• Moshayedi, A., Mochel, M. C., Brooks, A. N., Laver, J., & Salkey, K. S. (2022). A 9‐year‐old girl with blisters on the hands and face: An early presentation of Variegate Porphyria. Pediatric Dermatology, 40(2), 326–329.
• Northrop, A., Byers, H. A., & Radhakrishnan, S. K. (2020). Regulation of NRF1, a master transcription factor of proteasome genes: implications for cancer and neurodegeneration. Molecular Biology of the Cell, 31(20), 2158-2163.
• Northrop, A., Vangala, J. R., Feygin, A., & Radhakrishnan, S. K. (2020). Disabling the Protease DDI2 Attenuates the Transcriptional Activity of NRF1 and Potentiates Proteasome Inhibitor Cytotoxicity. International Journal of Molecular Sciences, 21(1), 327.